Literature DB >> 2693562

The role of CEA, TPA and CA 19-9 in the early detection of recurrent colorectal cancer.

P Barillari1, G Ramacciato, R de Angelis, P Gozzo, P Aurello, M Indinnimeo, S Valabrega, F D'Angelo, G Fegiz.   

Abstract

Eighty-eight consecutive patients who underwent curative resection for colorectal cancer between 1983 and 1985 were studied prospectively to evaluate the roles of sequential CEA, TPA and CA 19-9 determinations and independent clinical examination in the early diagnosis of resectable recurrences. Twenty nine recurrences were detected between 8 and 38 months after primary surgery. CEA, TPA and CA 19-9 showed a sensitivity of 72%, 62% and 38%, and a specificity of 78%, 86% and 97%, respectively. Of eight recurrences in which CEA was not raised, five induced a rise in TPA and two a rise in CA 19-9. The rise in the serum concentration of one of the three markers was the first sign of relapse in 23 (79%) patients. Two second-look laparotomies based solely on a rise in serum markers were performed. In one case diffuse recurrent disease was found, and in the other a resectable solitary hepatic metastasis was found.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2693562     DOI: 10.1007/bf01644987

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  17 in total

1.  Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer.

Authors:  H J Staab; F A Anderer; E Stumpf; A Hornung; R Fischer; G Kieninger
Journal:  Am J Surg       Date:  1985-02       Impact factor: 2.565

2.  Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigen.

Authors:  E W Martin; M Cooperman; L C Carey; J P Minton
Journal:  J Surg Res       Date:  1980-05       Impact factor: 2.192

3.  Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer.

Authors:  H F Sears; M Herlyn; B Del Villano; Z Steplewski; H Koprowski
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

4.  Specific antigen in serum of patients with colon carcinoma.

Authors:  H Koprowski; M Herlyn; Z Steplewski; H F Sears
Journal:  Science       Date:  1981-04-03       Impact factor: 47.728

5.  Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery.

Authors:  C Fucini; S M Tommasi; S Rosi; G Malatantis; G Cardona; S Panichi; U Bettini
Journal:  Dis Colon Rectum       Date:  1987-04       Impact factor: 4.585

6.  Follow-up of patients with colorectal cancer.

Authors:  K E Deveney; L W Way
Journal:  Am J Surg       Date:  1984-12       Impact factor: 2.565

7.  A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results.

Authors:  P H Sugarbaker; F J Gianola; A Dwyer; N R Neuman
Journal:  Surgery       Date:  1987-07       Impact factor: 3.982

8.  Postoperative screening of patients with carcinoma of the colon.

Authors:  R W Beart; P P Metzger; M J O'Connell; A J Schutt
Journal:  Dis Colon Rectum       Date:  1981 Nov-Dec       Impact factor: 4.585

9.  CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma.

Authors:  E W Martin; J P Minton; L C Carey
Journal:  Ann Surg       Date:  1985-09       Impact factor: 12.969

10.  Role of carcinoembryonic antigen in detection of asymptomatic disseminated disease in colorectal carcinoma.

Authors:  I G Finlay; C S McArdle
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-16
View more
  3 in total

1.  Carcinoembryonic antigen and carbohydrate antigen 19-9 are prognostic predictors of colorectal cancer with unresectable liver metastasis.

Authors:  Yoshinobu Mitsuyama; Hiroaki Shiba; Koichiro Haruki; Yuki Fujiwara; Kenei Furukawa; Tomonori Iida; Takenori Hayashi; Masaichi Ogawa; Yuichi Ishida; Takeyuki Misawa; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Oncol Lett       Date:  2012-01-18       Impact factor: 2.967

2.  Differential expression of proteomics models of colorectal cancer, colorectal benign disease and healthy controls.

Authors:  Ming Liu; Chun-Feng Li; Hong-Sheng Chen; Luo-Qiang Lin; Chun-Peng Zhang; Jin-Lu Zhao; Yan Liu; Shu-Jun Zhang; Jun-Chao Jin; Lei Wang; Jia-Ren Liu
Journal:  Proteome Sci       Date:  2010-03-25       Impact factor: 2.480

3.  MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer.

Authors:  Chibo Liu; Chunqin Pan; Jianmin Shen; Haibao Wang; Liang Yong
Journal:  Int J Med Sci       Date:  2011-01-03       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.